References

REFERENCES

1. U.S. National Commission on AIDS. HIV Disease in Correctional Facilities. Washington: U.S. National Commission on AIDS; 1991.
   
2. Harrison P, Beck AJ. Prisoners in 2004. Washington: U.S. Department of Justice, Bureau of Justice Statistics; October 2005.
   
3. Maruschak L. HIV in Prisons, 2003. Washington: U.S. Department of Justice, Bureau of Justice Statistics; September 2005.
   
4. Maruschak L. HIV in Prisons and Jails, 2002. Washington: U.S. Department of Justice, Bureau of Justice Statistics; December 2004.
   
5. Hammett TM, Harmon P, Rhodes W. The Burden of Infectious Disease Among Inmates and Releasees from Correctional Facilities. In: The Health Status of Soon-to-Be-Released Inmates: A Report to Congress. Vol. 2. Chicago: National Commission on Correctional Health Care; March 2002.
   
6. Dean-Gaitor HD, Fleming PL. Epidemiology of AIDS in incarcerated persons in the United States, 1994-1996. Aids 1999; 13:2429-35.
   
7. Wang L, Smith L, et al. Disparity in Trends and Changing Patterns of Predictors of HIV Infection among Inmates Entering the New York State Department of Correctional Services: 1998-2003, NYS Department of Health, Albany. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections; February 5-8, 2006; Denver. Poster abstract 291.
   
8. Kassira EN, Bauserman RL, Tomoyasu N, Caldeira E, Swetz A, Solomon L. HIV and AIDS surveillance among inmates in Maryland prisons. J Urban Health 2001; 78:256-63.
   
9. Gido RL, Gaunay W. Acquired Immune Deficiency Syndrome: A Demographic Profile of New York State Inmate Mortalities. 4th ed. Albany, NY: New York State Commission of Correction; 1990.
   
10. Lyons JA, Greifinger RA, Flannery T. Deaths of New York State Inmates 1978-1992. Albany, NY: New York State Department of Correctional Services; 1994.
    
11. Harding TW. HIV/AIDS and Prisons. Report for WHO Global Programme on AIDS. May 1990.
    
12. Harding TW, Schaller G. HIV/AIDS and prisons: updating and policy review. A Survey Covering 55 Prison Systems in 31 Countries. Geneva: University Institute of Legal Medicine for the WHO Global Programme on AIDS; 1992.
    
13. Thomas PA, Moerings M. AIDS in Prison. Aldershot, England: Dartmouth Publishing Co.; 1994.
    
14. Hernandez R, Gutierrez C, Granados C, et al. Drug addiction and AIDS in prison populations. In: Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, British Columbia. Abstract D.1411.
    
15. Hammett TM. The burden of HIV among prisoners. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona. Abstract MoPEE3800.
    
16. Autores VV, Menoyo C, Suarez M, et al. Needle exchange programmes in prison are feasible. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona. Abstract TePuF5484.
    
17. Mikl J, Kelly KF, Smith PF, et al. Survival among NY State prison inmates with AIDS. In: Program and abstracts of the VII International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract M.C.3124.
    
18. Sharp V, Andrews A, Heyman R, et al. Comparison of first episode of PCP in community patients and inmates. In: Program and abstracts of the IV International Conference on AIDS; June 4-9, 1989; Montreal. Abstract T.B.P.18.
    
19. The Correctional Association of New York. AIDS in Prison Report. June 1988.
    
20. Guerrero RA, Humet V, Laliga A, et al. Diagnostic delay related to HIV infection in patients with prison history. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona. Abstract MoPeC3390.
    
21. Castro K, Shansky R, Scardino V, et al. HIV transmission in correctional facilities. In: Program and abstracts of the VII International Conference on AIDS; June 16-21, 1991; Florence, Italy. Abstract M.C.3067.
    
22. Brewer TF, Vlahov D, Taylor E, Hall D, Munoz A, Polk BF. Transmission of HIV-1 within a statewide prison system. Aids 1988; 2:363-7.
    
23. Horsburgh CR, Jr., Jarvis JQ, McArther T, Ignacio T, Stock P. Seroconversion to human immunodeficiency virus in prison inmates. Am J Public Health 1990; 80:209-10.
    
24. Mutter RC, Grimes RM, Labarthe D. Evidence of intraprison spread of HIV infection. Arch Intern Med 1994; 154:793-5.
    
25. Yirrell DL, Goldberg DJ, Robertson P, et al. Molecular investigation confirming an outbreak of HIV in a Scottish prison. In: Program and abstracts of the XI International Conference on AIDS; July 7-12, 1996; Vancouver, Canada. Abstract Mo.C.1532.
    
26. Centers for Disease Control and Prevention (CDC). HIV transmission among male inmates in a state prison system--Georgia, 1992-2005. MMWR Morb Mortal Wkly Rep. 2006 Apr 21;55(15):421-6.
    
27. Hammett TM. 1990 Update: AIDS in Correctional Facilities. Washington: U.S. Department of Justice; 1991.
    
28. Nacci P, Kane T. Sex and Sexual Aggression in Federal Prisons. Washington: Federal Bureau of Prisons; 1982.
    
29. Decker MD, Vaughn WK, Brodie JS, Hutcheson RH, Jr., Schaffner W. Seroepidemiology of hepatitis B in Tennessee prisoners. J Infect Dis 1984; 150:450-9.
    
30. Mahon N. New York inmates' HIV risk behaviors: the implications for prevention policy and programs. Am J Public Health 1996; 86:1211-5.
    
31. Turnbull PJ, Dolan KA, Stimson GV, et al. Prison decreases the prevalence of behaviours but increases the risks. In: Program and abstracts of the VIII International Conference on AIDS; July 19-24, 1992; Amsterdam. Abstract PoC4321.
    
32. Carvell AL, Hart GJ. Risk behaviours for HIV infection among drug users in prison. Bmj 1990; 300:1383-4.
    
33. Reindollar RW. Hepatitis C and the correctional population. Am J Med 1999; 107:100S-103S.
    
34. Colton C. Hepatitis C Virus and HIV Co-infection in Corrections. Infectious Disease in Corrections Report, October 2005 8(10) 1-4.
    
35. Snider DE, Jr., Hutton MD. Tuberculosis in correctional institutions. Jama 1989; 261:436-7.
    
36. Braun MM, Truman BI, Maguire B, DiFerdinando GT, Jr., Wormser G, Broaddus R, Morse DL. Increasing incidence of tuberculosis in a prison inmate population. Association with HIV infection. Jama 1989; 261:393-7.
    
37. MacNeil JR, Lobato MN, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005; 95:1800-5.
    
38. Transmission of multidrug-resistant tuberculosis among immunocompromised persons in a correctional system--New York, 1991. MMWR Morb Mortal Wkly Rep 1992; 41:507-9.
    
39. Probable transmission of multidrug-resistant tuberculosis in a correctional facility--California. MMWR Morb Mortal Wkly Rep 1993; 42:48-51.
    
40. Tuberculosis outbreaks in prison housing units for HIV-infected inmates--California, 1995-1996. MMWR Morb Mortal Wkly Rep 1999; 48:79-82.
    
41. Drug-susceptible tuberculosis outbreak in a state correctional facility housing HIV-infected inmates--South Carolina, 1999-2000. MMWR Morb Mortal Wkly Rep 2000; 49:1041-4.
    
42. Hammett TM, Harrold L. Tuberculosis in Correctional Facilities. Washington: U.S. Department of Justice; 1994.
    
43. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep 1989; 38:313-20, 325.
    
44. Prevention and control of tuberculosis in correctional institutions: recommendations of the Advisory Committee for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1996;45:RR-8.
    
45. Jensen PA, Lambert LA, Iademarco MF, Ridzon R. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005; 54:1-141.
    
46. Bernard K, Sueker JJ, et al. Provider Perspectives about the Standard of HIV Care in Correctional Settings and Comparison to the Community Standard of Care: How Do We Measure Up? Infectious Diseases in Corrections Report. March 2006 9(3) 1-5.
    
47. Gajewski-Verbanac L, Lewis SM, Chrisman C, et al. Retrospective analysis of antiretroviral treatment guidelines in a national correctional base. In: Program and abstracts of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 26-29, 1999; San Francisco. Abstract 600.
    
48. Shuter J. Communicable Diseases in Inmates; Public Health Opportunities. In: The Health Status of Soon-to-Be-Released Inmates: A Report to Congress. Chicago: National Commission on Correctional Health Care; March 2002.
    
49. Sosman JM, Baker J, Catz SL, et al. Clinical and immune recovery during antiretroviral therapy among HIV-infected prisoners. In: Program and abstracts of the XIV International AIDS Conference; July 7-12, 2002; Barcelona. Abstract MoPeB3263.
    
50. Altice FL, Mostashari F, Friedland GH. Trust and the acceptance of and adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2001; 28:47-58.
    
51. WHO Guidelines on HIV Infection and AIDS in Prisons. Geneva: World Health Organization; 1993.
    
52. National Commission on Correctional Health Care. Clinical Guideline for Correctional Facilities. Management of Persons with HIV Infections. Chicago: National Commission on Correctional Health Care; November 11, 2001.
    
53. Standards for Health Services in Correctional Institutions, 3rd ed. Washington: American Public Health Association; 2003.
    
54. Personal communication with L Maruschak, Bureau of Justice Statistics, March 2006.
    
55. Sabin KM, Frey RL, Jr., Horsley R, Greby SM. Characteristics and trends of newly identified HIV infections among incarcerated populations: CDC HIV voluntary counseling, testing, and referral system, 1992-1998. J Urban Health 2001; 78:241-55.
    
56. Andrus JK, Fleming DW, Knox C, McAlister RO, Skeels MR, Conrad RE, Horan JM, Foster LR. HIV testing in prisoners: is mandatory testing mandatory? Am J Public Health 1989; 79:840-2.
    
57. Varghese B, Peterman TA. Cost-effectiveness of HIV counseling and testing in US prisons. J Urban Health 2001; 78:304-12.
    
58. Allard F, April N, Martin C, et al. Knowledge and attitudes of correctional facilities staff towards HIV and HBV infections. In: Program and abstracts of the VIII International Conference on AIDS; July 19-24, 1992; Amsterdam. Abstract PuD 9003.
    
59. Stewart L. The relationship between AIDS education, risk perception and quality of life for HIV-infected inmates in Pennsylvania prisons. In: Program and abstracts of the VIII International Conference on AIDS; July 19-24, 1992; Amsterdam. Abstract PoD 5070.
    
60. Dolan K, Rutter S, Wodak AD. Prison-based syringe exchange programmes: a review of international research and development. Addiction 2003; 98:153-8.
    
61. Nelles J, Fuhrer A, Hirsbrunner H, Harding T. Provision of syringes: the cutting edge of harm reduction in prison? Bmj 1998; 317:270-3.
    
62. Laporte JD, Bolinni P. Management of HIV/AIDS-related problems: situation in European prisons. In: Program and abstracts of the XII World AIDS Conference; June 28-July 3, 1998; Geneva. Abstract 44193.
    
63. Dolan KA, Wodak AD, Hall WD. Methadone maintenance treatment reduces heroin injection in New South Wales prisons. Drug Alcohol Rev 1998; 17:153-8.
    
64. Vigilante KC, Rich JD, Affleck P, et al. The women's HIV prison prevention program: reduction of prison recidivism may suggest HIV risk reduction. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections; January 22-26, 1997; Washington. Abstract 524.
    
65. Paar D, Thomas D, et al. Research in corrections. Infectious Diseases in Corrections Report. September 2005 8(9) 1-3.
    
66. Dubler NN, Sidel VW. On research on HIV infection and AIDS in correctional institutions. Milbank Q 1989; 67:171-207.
    
67. Hammett TM, Widom R, Epstein J, et al. 1994 Update: HIV/AIDS and STDs in Correctional Facilities. Washington: U.S. Department of Justice, National Institute of Justice, Centers for Disease Control and Prevention; 1995.
    
68. Altice FL, Mostashari F, Thompson AS, et al. Perceptions, acceptance and adherence to antiretrovirals among prisoners. In: Programs and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections; January 22-26, 1997; Washington. Abstract 253.
    
69. Gostin L, Porter L. AIDS Litigation Project II: A National Survey of Federal, State and Local Cases Before Courts and Human Rights Commissions. Objective Description of Trends in AIDS Litigation. Washington: Department of Health and Human Services, Public Health Service, National AIDS Program Office; 1991.
    
70. Gostin L, Porter L, Sandomire H. AIDS Litigation Project: A National Survey of Federal, State and Local Cases Before Courts and Human Rights Commissions. Washington: Department of Health and Human Services, Public Health Service, Office of the Assistant Secretary for Health, Office of Public Health Service HIV/AIDS Coordination; 1990.
    
71. Greenspan J. Transmission laws: the repression of HIV positive persons. In: The Exchange. San Francisco: National Lawyers Guild; October 1990;13:3-5.